

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | histone H3-K4 trimethylation (GO:0080182) | 4.84183444 |
| 2 | detection of molecule of bacterial origin (GO:0032490) | 4.52365978 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.49084063 |
| 4 | establishment of protein localization to Golgi (GO:0072600) | 4.37240677 |
| 5 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.27327778 |
| 6 | peptidyl-lysine trimethylation (GO:0018023) | 4.22034548 |
| 7 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.14721110 |
| 8 | protein targeting to Golgi (GO:0000042) | 4.11823134 |
| 9 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.10519589 |
| 10 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.08629073 |
| 11 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 4.01801902 |
| 12 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.99494533 |
| 13 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.99494533 |
| 14 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.99494533 |
| 15 | microglial cell activation (GO:0001774) | 3.92077698 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.84702210 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.84702210 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 3.81675774 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.81675774 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.81675774 |
| 21 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.81675774 |
| 22 | modulation by symbiont of host immune response (GO:0052553) | 3.81675774 |
| 23 | positive regulation by symbiont of host defense response (GO:0052509) | 3.81675774 |
| 24 | activated T cell proliferation (GO:0050798) | 3.56272032 |
| 25 | cellular extravasation (GO:0045123) | 3.56027153 |
| 26 | histone H3-K9 modification (GO:0061647) | 3.52868590 |
| 27 | histone H3-K9 methylation (GO:0051567) | 3.47631033 |
| 28 | neutrophil mediated immunity (GO:0002446) | 3.45008993 |
| 29 | neural tube formation (GO:0001841) | 3.39393571 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 3.38142242 |
| 31 | pre-miRNA processing (GO:0031054) | 3.38014684 |
| 32 | interkinetic nuclear migration (GO:0022027) | 3.37128476 |
| 33 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.36939087 |
| 34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.35549013 |
| 35 | macrophage activation involved in immune response (GO:0002281) | 3.33000353 |
| 36 | peptidyl-lysine methylation (GO:0018022) | 3.30889714 |
| 37 | negative regulation of T cell mediated immunity (GO:0002710) | 3.29120096 |
| 38 | macrophage activation (GO:0042116) | 3.24998963 |
| 39 | cytoplasmic mRNA processing body assembly (GO:0033962) | 3.17676676 |
| 40 | myeloid leukocyte mediated immunity (GO:0002444) | 3.14909433 |
| 41 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.09323114 |
| 42 | B cell receptor signaling pathway (GO:0050853) | 3.08838726 |
| 43 | response to interleukin-15 (GO:0070672) | 3.08592448 |
| 44 | histone mRNA catabolic process (GO:0071044) | 3.07317752 |
| 45 | negative regulation of B cell proliferation (GO:0030889) | 3.04126617 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.03608737 |
| 47 | histone H3-K36 demethylation (GO:0070544) | 3.01676079 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.99907498 |
| 49 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.99718030 |
| 50 | detection of external biotic stimulus (GO:0098581) | 2.96557195 |
| 51 | positive T cell selection (GO:0043368) | 2.92742497 |
| 52 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.91118292 |
| 53 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.90008565 |
| 54 | cellular response to ethanol (GO:0071361) | 2.87575544 |
| 55 | protein K11-linked deubiquitination (GO:0035871) | 2.86211777 |
| 56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.85759895 |
| 57 | centrosome localization (GO:0051642) | 2.80710965 |
| 58 | histone H3-K4 methylation (GO:0051568) | 2.78602084 |
| 59 | negative T cell selection (GO:0043383) | 2.78183881 |
| 60 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.78165658 |
| 61 | response to host immune response (GO:0052572) | 2.78165658 |
| 62 | cellular response to interleukin-15 (GO:0071350) | 2.78076842 |
| 63 | hepatocyte apoptotic process (GO:0097284) | 2.77651843 |
| 64 | negative thymic T cell selection (GO:0045060) | 2.74648238 |
| 65 | regulation of RNA export from nucleus (GO:0046831) | 2.74215434 |
| 66 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.72878385 |
| 67 | regulation of establishment of cell polarity (GO:2000114) | 2.69816507 |
| 68 | positive regulation of granulocyte differentiation (GO:0030854) | 2.69186179 |
| 69 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.68266286 |
| 70 | negative regulation of B cell mediated immunity (GO:0002713) | 2.65131563 |
| 71 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.65131563 |
| 72 | protein targeting to lysosome (GO:0006622) | 2.64232743 |
| 73 | establishment of protein localization to vacuole (GO:0072666) | 2.64232743 |
| 74 | protein targeting to vacuole (GO:0006623) | 2.64232743 |
| 75 | histone lysine methylation (GO:0034968) | 2.62371559 |
| 76 | interferon-gamma production (GO:0032609) | 2.61961370 |
| 77 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.61897920 |
| 78 | response to host (GO:0075136) | 2.61897920 |
| 79 | response to host defenses (GO:0052200) | 2.61897920 |
| 80 | protein localization to Golgi apparatus (GO:0034067) | 2.60052943 |
| 81 | detection of biotic stimulus (GO:0009595) | 2.56358178 |
| 82 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.56183213 |
| 83 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.54952521 |
| 84 | regulation of beta-amyloid formation (GO:1902003) | 2.52153629 |
| 85 | nerve growth factor signaling pathway (GO:0038180) | 2.51508715 |
| 86 | protein K48-linked deubiquitination (GO:0071108) | 2.51145816 |
| 87 | nucleus localization (GO:0051647) | 2.50821213 |
| 88 | histone H3-K9 demethylation (GO:0033169) | 2.49370462 |
| 89 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.48110839 |
| 90 | detection of other organism (GO:0098543) | 2.46469608 |
| 91 | negative regulation of adaptive immune response (GO:0002820) | 2.46254404 |
| 92 | dosage compensation (GO:0007549) | 2.44493240 |
| 93 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.41385762 |
| 94 | negative regulation of neurotransmitter transport (GO:0051589) | 2.39574519 |
| 95 | establishment of nucleus localization (GO:0040023) | 2.39386804 |
| 96 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.38413207 |
| 97 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.37106177 |
| 98 | peptidyl-threonine phosphorylation (GO:0018107) | 2.37061604 |
| 99 | microtubule anchoring (GO:0034453) | 2.36065982 |
| 100 | positive thymic T cell selection (GO:0045059) | 2.35945183 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.48880557 |
| 2 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.95561868 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.90907749 |
| 4 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.87040482 |
| 5 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.71249971 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.49405605 |
| 7 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.13638781 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.04926378 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.04523147 |
| 10 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.96197193 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.94385187 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.93666830 |
| 13 | TP53_16413492_ChIP-PET_HCT116_Human | 1.92435705 |
| 14 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.90384307 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.90105534 |
| 16 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86241683 |
| 17 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.78188065 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.77301288 |
| 19 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.73077600 |
| 20 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.72043294 |
| 21 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.70613894 |
| 22 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.70613894 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.65369914 |
| 24 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63225676 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.61134694 |
| 26 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.60720302 |
| 27 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.52772872 |
| 28 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.50806471 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50719543 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.49579330 |
| 31 | STAT3_23295773_ChIP-Seq_U87_Human | 1.47823733 |
| 32 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.47273282 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46782708 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.45456590 |
| 35 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.45184575 |
| 36 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.44439699 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.43475790 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.43216682 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.42096495 |
| 40 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.41550904 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.39922628 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.37015097 |
| 43 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.36985306 |
| 44 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34664689 |
| 45 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.34561725 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.32190436 |
| 47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.32185961 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.31995315 |
| 49 | TCF4_23295773_ChIP-Seq_U87_Human | 1.31625807 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.31137409 |
| 51 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.28986273 |
| 52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28665724 |
| 53 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.26754340 |
| 54 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.26096248 |
| 55 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.26028321 |
| 56 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23149404 |
| 57 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.22548602 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.21995689 |
| 59 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.21911623 |
| 60 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.18735591 |
| 61 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17144766 |
| 62 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.16331150 |
| 63 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16025159 |
| 64 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.11768752 |
| 65 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11399244 |
| 66 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.11283624 |
| 67 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10190534 |
| 68 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.09280253 |
| 69 | MYB_26560356_Chip-Seq_TH2_Human | 1.08248769 |
| 70 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07854614 |
| 71 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07276588 |
| 72 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.06137640 |
| 73 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05522453 |
| 74 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.05258144 |
| 75 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04680224 |
| 76 | FUS_26573619_Chip-Seq_HEK293_Human | 1.04137630 |
| 77 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.03650100 |
| 78 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.03508589 |
| 79 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.03320506 |
| 80 | EWS_26573619_Chip-Seq_HEK293_Human | 1.03177661 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.02741561 |
| 82 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.02192725 |
| 83 | KDM2B_26808549_Chip-Seq_REH_Human | 1.01884573 |
| 84 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.01447351 |
| 85 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01017572 |
| 86 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.00832967 |
| 87 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.00128679 |
| 88 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99640756 |
| 89 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99313940 |
| 90 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.99194837 |
| 91 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.97797639 |
| 92 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.97453490 |
| 93 | MYB_26560356_Chip-Seq_TH1_Human | 0.96716977 |
| 94 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96220256 |
| 95 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95884763 |
| 96 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95884763 |
| 97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95667736 |
| 98 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.95042934 |
| 99 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95025709 |
| 100 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92856210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 7.49459471 |
| 2 | MP0003787_abnormal_imprinting | 6.37639098 |
| 3 | MP0008057_abnormal_DNA_replication | 4.78796854 |
| 4 | MP0008877_abnormal_DNA_methylation | 4.00805251 |
| 5 | MP0003724_increased_susceptibility_to | 3.11884281 |
| 6 | MP0003121_genomic_imprinting | 3.00893936 |
| 7 | MP0002396_abnormal_hematopoietic_system | 2.58887776 |
| 8 | MP0004381_abnormal_hair_follicle | 2.47392953 |
| 9 | MP0005174_abnormal_tail_pigmentation | 2.25517078 |
| 10 | MP0000015_abnormal_ear_pigmentation | 2.18675602 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.07869176 |
| 12 | MP0003890_abnormal_embryonic-extraembry | 1.99312372 |
| 13 | MP0001835_abnormal_antigen_presentation | 1.98260778 |
| 14 | MP0003303_peritoneal_inflammation | 1.88287207 |
| 15 | MP0001800_abnormal_humoral_immune | 1.84884965 |
| 16 | MP0008260_abnormal_autophagy | 1.82776267 |
| 17 | MP0003763_abnormal_thymus_physiology | 1.79407872 |
| 18 | MP0004883_abnormal_blood_vessel | 1.65938097 |
| 19 | MP0005409_darkened_coat_color | 1.47387616 |
| 20 | MP0003828_pulmonary_edema | 1.44032726 |
| 21 | MP0002419_abnormal_innate_immunity | 1.43301475 |
| 22 | MP0002166_altered_tumor_susceptibility | 1.40246090 |
| 23 | MP0000685_abnormal_immune_system | 1.36264694 |
| 24 | MP0002420_abnormal_adaptive_immunity | 1.35989862 |
| 25 | MP0002723_abnormal_immune_serum | 1.35084945 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.34958069 |
| 27 | MP0001819_abnormal_immune_cell | 1.32552435 |
| 28 | MP0006292_abnormal_olfactory_placode | 1.29677687 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.28427029 |
| 30 | MP0002398_abnormal_bone_marrow | 1.28176881 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.26288822 |
| 32 | MP0004130_abnormal_muscle_cell | 1.25760648 |
| 33 | MP0003221_abnormal_cardiomyocyte_apopto | 1.25425048 |
| 34 | MP0004808_abnormal_hematopoietic_stem | 1.24630475 |
| 35 | MP0002009_preneoplasia | 1.23694572 |
| 36 | MP0000427_abnormal_hair_cycle | 1.23185544 |
| 37 | MP0000778_abnormal_nervous_system | 1.21955839 |
| 38 | MP0006054_spinal_hemorrhage | 1.21048741 |
| 39 | MP0003122_maternal_imprinting | 1.20667363 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.18570767 |
| 41 | MP0003436_decreased_susceptibility_to | 1.18378215 |
| 42 | MP0002405_respiratory_system_inflammati | 1.15670349 |
| 43 | MP0000716_abnormal_immune_system | 1.14397415 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.11412331 |
| 45 | MP0005310_abnormal_salivary_gland | 1.10718384 |
| 46 | MP0002928_abnormal_bile_duct | 1.07659134 |
| 47 | MP0003632_abnormal_nervous_system | 1.06783926 |
| 48 | MP0003091_abnormal_cell_migration | 1.06448481 |
| 49 | MP0005075_abnormal_melanosome_morpholog | 1.06237383 |
| 50 | MP0005387_immune_system_phenotype | 1.03110363 |
| 51 | MP0001790_abnormal_immune_system | 1.03110363 |
| 52 | MP0003690_abnormal_glial_cell | 1.02093156 |
| 53 | MP0000428_abnormal_craniofacial_morphol | 1.00090924 |
| 54 | MP0000689_abnormal_spleen_morphology | 0.98806585 |
| 55 | MP0000371_diluted_coat_color | 0.98246400 |
| 56 | MP0005000_abnormal_immune_tolerance | 0.96310810 |
| 57 | MP0004484_altered_response_of | 0.95509099 |
| 58 | MP0002722_abnormal_immune_system | 0.95005213 |
| 59 | MP0005164_abnormal_response_to | 0.94891029 |
| 60 | MP0005025_abnormal_response_to | 0.93441935 |
| 61 | MP0003045_fibrosis | 0.92944954 |
| 62 | MP0005671_abnormal_response_to | 0.92789845 |
| 63 | MP0003656_abnormal_erythrocyte_physiolo | 0.90177164 |
| 64 | MP0002909_abnormal_adrenal_gland | 0.89959608 |
| 65 | MP0002006_tumorigenesis | 0.89731517 |
| 66 | MP0001188_hyperpigmentation | 0.89177216 |
| 67 | MP0002638_abnormal_pupillary_reflex | 0.85560142 |
| 68 | MP0001851_eye_inflammation | 0.83003044 |
| 69 | MP0003866_abnormal_defecation | 0.81799427 |
| 70 | MP0010307_abnormal_tumor_latency | 0.80989250 |
| 71 | MP0004142_abnormal_muscle_tone | 0.78542267 |
| 72 | MP0008961_abnormal_basal_metabolism | 0.78388269 |
| 73 | MP0002332_abnormal_exercise_endurance | 0.77912567 |
| 74 | MP0004885_abnormal_endolymph | 0.75820942 |
| 75 | MP0003631_nervous_system_phenotype | 0.75048540 |
| 76 | MP0002429_abnormal_blood_cell | 0.74603340 |
| 77 | MP0009115_abnormal_fat_cell | 0.73207924 |
| 78 | MP0000383_abnormal_hair_follicle | 0.70869130 |
| 79 | MP0002095_abnormal_skin_pigmentation | 0.70044233 |
| 80 | MP0003635_abnormal_synaptic_transmissio | 0.68957561 |
| 81 | MP0001958_emphysema | 0.64588998 |
| 82 | MP0002063_abnormal_learning/memory/cond | 0.63543964 |
| 83 | MP0002133_abnormal_respiratory_system | 0.63440684 |
| 84 | MP0005388_respiratory_system_phenotype | 0.63440684 |
| 85 | MP0001545_abnormal_hematopoietic_system | 0.63278883 |
| 86 | MP0005397_hematopoietic_system_phenotyp | 0.63278883 |
| 87 | MP0003633_abnormal_nervous_system | 0.62811125 |
| 88 | MP0004811_abnormal_neuron_physiology | 0.62522675 |
| 89 | MP0005621_abnormal_cell_physiology | 0.61867651 |
| 90 | MP0003115_abnormal_respiratory_system | 0.60787545 |
| 91 | MP0002067_abnormal_sensory_capabilities | 0.60276160 |
| 92 | MP0001186_pigmentation_phenotype | 0.54697717 |
| 93 | MP0000955_abnormal_spinal_cord | 0.54695979 |
| 94 | MP0004742_abnormal_vestibular_system | 0.53576464 |
| 95 | MP0001440_abnormal_grooming_behavior | 0.52467209 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.51895226 |
| 97 | MP0010678_abnormal_skin_adnexa | 0.51890557 |
| 98 | MP0002168_other_aberrant_phenotype | 0.51136814 |
| 99 | MP0001784_abnormal_fluid_regulation | 0.48694846 |
| 100 | MP0001486_abnormal_startle_reflex | 0.48408131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 4.07600723 |
| 2 | Papillary thyroid carcinoma (HP:0002895) | 3.98120858 |
| 3 | Volvulus (HP:0002580) | 3.83476509 |
| 4 | Subacute progressive viral hepatitis (HP:0006572) | 3.37053155 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.36677333 |
| 6 | T lymphocytopenia (HP:0005403) | 3.27298941 |
| 7 | Optic neuritis (HP:0100653) | 3.21903427 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 3.21903427 |
| 9 | Genetic anticipation (HP:0003743) | 3.15691685 |
| 10 | Abnormality of T cell number (HP:0011839) | 3.01717302 |
| 11 | Difficulty running (HP:0009046) | 2.95618770 |
| 12 | Orchitis (HP:0100796) | 2.87532432 |
| 13 | Truncal obesity (HP:0001956) | 2.87440083 |
| 14 | Eczematoid dermatitis (HP:0000976) | 2.75370458 |
| 15 | Hyperventilation (HP:0002883) | 2.74428735 |
| 16 | Recurrent abscess formation (HP:0002722) | 2.67977767 |
| 17 | Myositis (HP:0100614) | 2.64795920 |
| 18 | Peritonitis (HP:0002586) | 2.59110165 |
| 19 | Abnormality of incisor morphology (HP:0011063) | 2.54111096 |
| 20 | Recurrent fungal infections (HP:0002841) | 2.50050090 |
| 21 | Hip dysplasia (HP:0001385) | 2.49493252 |
| 22 | Aqueductal stenosis (HP:0002410) | 2.48386270 |
| 23 | Abnormal hair whorl (HP:0010721) | 2.44237515 |
| 24 | Protruding tongue (HP:0010808) | 2.42125933 |
| 25 | Narrow palate (HP:0000189) | 2.42044835 |
| 26 | Acute myeloid leukemia (HP:0004808) | 2.39657847 |
| 27 | Keratoconjunctivitis sicca (HP:0001097) | 2.35860138 |
| 28 | Abnormality of the fingertips (HP:0001211) | 2.34228089 |
| 29 | Gastrointestinal infarctions (HP:0005244) | 2.34126750 |
| 30 | Tapered finger (HP:0001182) | 2.30401168 |
| 31 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.29890560 |
| 32 | Viral hepatitis (HP:0006562) | 2.28673421 |
| 33 | Low anterior hairline (HP:0000294) | 2.27510708 |
| 34 | Papilledema (HP:0001085) | 2.27446088 |
| 35 | Widely spaced teeth (HP:0000687) | 2.26988145 |
| 36 | Gingivitis (HP:0000230) | 2.20509314 |
| 37 | Stomach cancer (HP:0012126) | 2.19068138 |
| 38 | Recurrent cutaneous fungal infections (HP:0011370) | 2.19011642 |
| 39 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.19011642 |
| 40 | Thyroid carcinoma (HP:0002890) | 2.17839252 |
| 41 | Absent frontal sinuses (HP:0002688) | 2.16477221 |
| 42 | Keratoconjunctivitis (HP:0001096) | 2.16126292 |
| 43 | Abnormality of the ischium (HP:0003174) | 2.15787973 |
| 44 | Postural instability (HP:0002172) | 2.12881977 |
| 45 | Overgrowth (HP:0001548) | 2.11827750 |
| 46 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.11175220 |
| 47 | Hepatoblastoma (HP:0002884) | 2.09383591 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.08420576 |
| 49 | Recurrent skin infections (HP:0001581) | 2.08185712 |
| 50 | Febrile seizures (HP:0002373) | 2.07053257 |
| 51 | Vertebral arch anomaly (HP:0008438) | 2.06885576 |
| 52 | Cystic hygroma (HP:0000476) | 2.04333082 |
| 53 | Neonatal hypoglycemia (HP:0001998) | 2.01631950 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.00779000 |
| 55 | Long eyelashes (HP:0000527) | 2.00364372 |
| 56 | Hypoplastic ischia (HP:0003175) | 1.99722869 |
| 57 | Gaze-evoked nystagmus (HP:0000640) | 1.95507443 |
| 58 | Progressive cerebellar ataxia (HP:0002073) | 1.95484138 |
| 59 | Fair hair (HP:0002286) | 1.94271224 |
| 60 | Oligodactyly (hands) (HP:0001180) | 1.93936508 |
| 61 | Heterotopia (HP:0002282) | 1.93828323 |
| 62 | Inappropriate behavior (HP:0000719) | 1.92964011 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 1.92961951 |
| 64 | Excessive salivation (HP:0003781) | 1.92028501 |
| 65 | Prominent nose (HP:0000448) | 1.91563408 |
| 66 | Generalized hypopigmentation of hair (HP:0011358) | 1.90610363 |
| 67 | Macroorchidism (HP:0000053) | 1.90547962 |
| 68 | Drooling (HP:0002307) | 1.88262166 |
| 69 | Stomatitis (HP:0010280) | 1.83657043 |
| 70 | Leukocytosis (HP:0001974) | 1.82495411 |
| 71 | Tented upper lip vermilion (HP:0010804) | 1.80832069 |
| 72 | Sandal gap (HP:0001852) | 1.80732037 |
| 73 | Thyroiditis (HP:0100646) | 1.79491117 |
| 74 | Curly hair (HP:0002212) | 1.78440548 |
| 75 | Supernumerary ribs (HP:0005815) | 1.77995738 |
| 76 | Encephalitis (HP:0002383) | 1.76368137 |
| 77 | Acute lymphatic leukemia (HP:0006721) | 1.73937663 |
| 78 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.73819307 |
| 79 | Hemoptysis (HP:0002105) | 1.72181825 |
| 80 | Obstructive sleep apnea (HP:0002870) | 1.71233510 |
| 81 | Thick eyebrow (HP:0000574) | 1.70128983 |
| 82 | Absent speech (HP:0001344) | 1.68817798 |
| 83 | Dislocated radial head (HP:0003083) | 1.68277569 |
| 84 | Hypoplasia of the maxilla (HP:0000327) | 1.66686566 |
| 85 | Arterial thrombosis (HP:0004420) | 1.65785381 |
| 86 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.64742250 |
| 87 | Abnormality of the radial head (HP:0003995) | 1.64020987 |
| 88 | Bladder neoplasm (HP:0009725) | 1.63973094 |
| 89 | Bladder carcinoma (HP:0002862) | 1.63973094 |
| 90 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.61815071 |
| 91 | Abnormality of the right ventricle (HP:0001707) | 1.61658498 |
| 92 | Neoplasm of the adrenal cortex (HP:0100641) | 1.61593195 |
| 93 | Keratitis (HP:0000491) | 1.61343199 |
| 94 | Chest pain (HP:0100749) | 1.60619222 |
| 95 | Gingival bleeding (HP:0000225) | 1.60081175 |
| 96 | Vasculitis (HP:0002633) | 1.59182064 |
| 97 | Obsessive-compulsive behavior (HP:0000722) | 1.59138330 |
| 98 | Mediastinal lymphadenopathy (HP:0100721) | 1.58017833 |
| 99 | Abnormality of T cells (HP:0002843) | 1.57789367 |
| 100 | Hypoplastic iliac wings (HP:0002866) | 1.57207162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.37391313 |
| 2 | RIPK4 | 2.47458626 |
| 3 | SGK2 | 2.15104470 |
| 4 | WNK1 | 2.09991831 |
| 5 | TAOK3 | 2.06900399 |
| 6 | BLK | 1.95646658 |
| 7 | CSK | 1.89338551 |
| 8 | CDK12 | 1.88539079 |
| 9 | TNIK | 1.80425078 |
| 10 | CAMK1G | 1.72006666 |
| 11 | FES | 1.70365189 |
| 12 | BRD4 | 1.70347401 |
| 13 | AKT3 | 1.66933217 |
| 14 | BMPR1B | 1.64682189 |
| 15 | SGK3 | 1.64268551 |
| 16 | MAP3K6 | 1.58490172 |
| 17 | MARK2 | 1.54454379 |
| 18 | IRAK4 | 1.50677378 |
| 19 | CAMK1D | 1.49003884 |
| 20 | FGFR3 | 1.46901313 |
| 21 | YES1 | 1.42332479 |
| 22 | SGK494 | 1.39280069 |
| 23 | SGK223 | 1.39280069 |
| 24 | PTK2B | 1.36157252 |
| 25 | CASK | 1.35042936 |
| 26 | FGR | 1.31630720 |
| 27 | ACVR1B | 1.30216075 |
| 28 | IRAK1 | 1.29938090 |
| 29 | MAP3K14 | 1.28332373 |
| 30 | MAP3K2 | 1.26398535 |
| 31 | PAK3 | 1.24089511 |
| 32 | JAK1 | 1.23738895 |
| 33 | TEC | 1.23720843 |
| 34 | PIK3CG | 1.23476551 |
| 35 | NLK | 1.19846968 |
| 36 | BTK | 1.19196444 |
| 37 | IKBKE | 1.18189864 |
| 38 | MAP4K1 | 1.16774035 |
| 39 | SIK2 | 1.12985632 |
| 40 | SYK | 1.10874930 |
| 41 | MAP2K3 | 1.08785103 |
| 42 | MAP2K4 | 1.04048719 |
| 43 | PNCK | 1.03060829 |
| 44 | SGK1 | 0.99617135 |
| 45 | STK11 | 0.98089520 |
| 46 | NTRK3 | 0.97799643 |
| 47 | JAK3 | 0.97464459 |
| 48 | HCK | 0.96860591 |
| 49 | MAPK13 | 0.95928741 |
| 50 | IRAK2 | 0.95461537 |
| 51 | TXK | 0.93640993 |
| 52 | HIPK2 | 0.93588856 |
| 53 | PDGFRB | 0.89553159 |
| 54 | KSR1 | 0.88696520 |
| 55 | TYK2 | 0.87093860 |
| 56 | DMPK | 0.87008951 |
| 57 | ERBB2 | 0.82440927 |
| 58 | MAP3K13 | 0.81778293 |
| 59 | JAK2 | 0.81310222 |
| 60 | WNK3 | 0.80832754 |
| 61 | GRK6 | 0.79712511 |
| 62 | DYRK1A | 0.79509734 |
| 63 | NUAK1 | 0.79149458 |
| 64 | MAP3K4 | 0.79145434 |
| 65 | RAF1 | 0.78507673 |
| 66 | MARK3 | 0.76976425 |
| 67 | TNK2 | 0.75237406 |
| 68 | MAP3K7 | 0.75083204 |
| 69 | FGFR2 | 0.73733313 |
| 70 | MKNK2 | 0.71452119 |
| 71 | PLK2 | 0.70265059 |
| 72 | MARK1 | 0.70113904 |
| 73 | LYN | 0.68217552 |
| 74 | ITK | 0.67050182 |
| 75 | CAMKK2 | 0.66549139 |
| 76 | NTRK2 | 0.63316900 |
| 77 | TRPM7 | 0.61687180 |
| 78 | BMPR2 | 0.61417683 |
| 79 | CHUK | 0.61105844 |
| 80 | EPHB1 | 0.60852932 |
| 81 | NEK6 | 0.58853280 |
| 82 | CAMK4 | 0.56568069 |
| 83 | LCK | 0.56032019 |
| 84 | TYRO3 | 0.55227190 |
| 85 | ZAP70 | 0.54978330 |
| 86 | MAP3K1 | 0.54946418 |
| 87 | CAMKK1 | 0.54433148 |
| 88 | MAP3K10 | 0.53515687 |
| 89 | MAPK7 | 0.52215510 |
| 90 | MELK | 0.52043562 |
| 91 | MAPK10 | 0.51476663 |
| 92 | PRKCH | 0.50890861 |
| 93 | OXSR1 | 0.50775895 |
| 94 | STK38 | 0.50623882 |
| 95 | RET | 0.49486716 |
| 96 | PRKCZ | 0.47345580 |
| 97 | STK4 | 0.44607082 |
| 98 | STK24 | 0.43133171 |
| 99 | PDK1 | 0.42167512 |
| 100 | CAMK1 | 0.41247517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.16398171 |
| 2 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.91356141 |
| 3 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.77709300 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.67896957 |
| 5 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.66696050 |
| 6 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.54025689 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.53439971 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.51689023 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.50438027 |
| 10 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.46012698 |
| 11 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.36946161 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36230726 |
| 13 | Endometrial cancer_Homo sapiens_hsa05213 | 1.35563264 |
| 14 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.35152984 |
| 15 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.31754410 |
| 16 | Long-term potentiation_Homo sapiens_hsa04720 | 1.31725373 |
| 17 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.29418371 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.28677400 |
| 19 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.26429402 |
| 20 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.24394680 |
| 21 | Platelet activation_Homo sapiens_hsa04611 | 1.23696854 |
| 22 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.23540749 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.23042247 |
| 24 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21837621 |
| 25 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.21832672 |
| 26 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21489444 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.21104503 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.20627837 |
| 29 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.19705392 |
| 30 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.17555360 |
| 31 | Colorectal cancer_Homo sapiens_hsa05210 | 1.16937027 |
| 32 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13483800 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12643569 |
| 34 | Hepatitis B_Homo sapiens_hsa05161 | 1.10765634 |
| 35 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.06361030 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.05790591 |
| 37 | Glioma_Homo sapiens_hsa05214 | 1.04368766 |
| 38 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.04332092 |
| 39 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.03265070 |
| 40 | Prostate cancer_Homo sapiens_hsa05215 | 1.02464613 |
| 41 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02457192 |
| 42 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.01050280 |
| 43 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.99709555 |
| 44 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.97038846 |
| 45 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.95481803 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95017980 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93876651 |
| 48 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.93335844 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 0.93014165 |
| 50 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.91491251 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91362253 |
| 52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.89980693 |
| 53 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.89048907 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.88638867 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.88043089 |
| 56 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.87356101 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.86160847 |
| 58 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86038307 |
| 59 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84703495 |
| 60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.83943769 |
| 61 | Lysine degradation_Homo sapiens_hsa00310 | 0.83311001 |
| 62 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.82038785 |
| 63 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.81819377 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.81039664 |
| 65 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.80106993 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79658123 |
| 67 | Nicotine addiction_Homo sapiens_hsa05033 | 0.79223083 |
| 68 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77787410 |
| 69 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.77579722 |
| 70 | Morphine addiction_Homo sapiens_hsa05032 | 0.77565548 |
| 71 | Malaria_Homo sapiens_hsa05144 | 0.75131076 |
| 72 | Axon guidance_Homo sapiens_hsa04360 | 0.74912185 |
| 73 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.74616830 |
| 74 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.73382452 |
| 75 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.73133841 |
| 76 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.71578683 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.70056465 |
| 78 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68848583 |
| 79 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.67719313 |
| 80 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.67571646 |
| 81 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.66711533 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.66015651 |
| 83 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.65407778 |
| 84 | Circadian entrainment_Homo sapiens_hsa04713 | 0.65259977 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.65214828 |
| 86 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65164906 |
| 87 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64982102 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63855428 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.63323527 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.61209368 |
| 91 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60536825 |
| 92 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60072304 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.59236128 |
| 94 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.58744496 |
| 95 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58626270 |
| 96 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58245314 |
| 97 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57898079 |
| 98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.57600686 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57477578 |
| 100 | Focal adhesion_Homo sapiens_hsa04510 | 0.56614366 |

